Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Alterations in skeletal muscle fatty acid handling predisposes middle-aged mice to diet-induced insulin resistance.

Koonen DP, Sung MM, Kao CK, Dolinsky VW, Koves TR, Ilkayeva O, Jacobs RL, Vance DE, Light PE, Muoio DM, Febbraio M, Dyck JR.

Diabetes. 2010 Jun;59(6):1366-75. doi: 10.2337/db09-1142. Epub 2010 Mar 18.

2.

A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.

Bonen A, Han XX, Habets DD, Febbraio M, Glatz JF, Luiken JJ.

Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1740-9. Epub 2007 Jan 30.

PMID:
17264223
3.

Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance.

Wilkes JJ, Lloyd DJ, Gekakis N.

Diabetes. 2009 May;58(5):1133-43. doi: 10.2337/db08-0245. Epub 2009 Feb 10.

4.

Role of CD36 in membrane transport of long-chain fatty acids.

Ibrahimi A, Abumrad NA.

Curr Opin Clin Nutr Metab Care. 2002 Mar;5(2):139-45. Review.

PMID:
11844979
5.

Insulin acutely upregulates protein expression of the fatty acid transporter CD36 in human skeletal muscle in vivo.

Corpeleijn E, Pelsers MM, Soenen S, Mensink M, Bouwman FG, Kooi ME, Saris WH, Glatz JF, Blaak EE.

J Physiol Pharmacol. 2008 Mar;59(1):77-83.

6.

Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats.

Bonen A, Holloway GP, Tandon NN, Han XX, McFarlan J, Glatz JF, Luiken JJ.

Am J Physiol Regul Integr Comp Physiol. 2009 Oct;297(4):R1202-12. doi: 10.1152/ajpregu.90820.2008. Epub 2009 Aug 12.

PMID:
19675275
7.
8.

Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity.

Koonen DP, Jacobs RL, Febbraio M, Young ME, Soltys CL, Ong H, Vance DE, Dyck JR.

Diabetes. 2007 Dec;56(12):2863-71. Epub 2007 Aug 29.

9.

Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss.

Kelley DE, Goodpaster B, Wing RR, Simoneau JA.

Am J Physiol. 1999 Dec;277(6 Pt 1):E1130-41.

PMID:
10600804
10.

Intracellular fatty acid metabolism in skeletal muscle and insulin resistance.

Koh EH, Lee WJ, Kim MS, Park JY, Lee IK, Lee KU.

Curr Diabetes Rev. 2005 Aug;1(3):331-6. Review.

PMID:
18220608
11.
12.

Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance.

Liu L, Zhang Y, Chen N, Shi X, Tsang B, Yu YH.

J Clin Invest. 2007 Jun;117(6):1679-89. Epub 2007 May 17.

13.

CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice.

Goudriaan JR, Dahlmans VE, Teusink B, Ouwens DM, Febbraio M, Maassen JA, Romijn JA, Havekes LM, Voshol PJ.

J Lipid Res. 2003 Dec;44(12):2270-7. Epub 2003 Aug 16.

14.

Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.

Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM.

Cell Metab. 2008 Jan;7(1):45-56. doi: 10.1016/j.cmet.2007.10.013.

15.

Exercise-induced alterations in muscle lipid metabolism improve insulin sensitivity.

Horowitz JF.

Exerc Sport Sci Rev. 2007 Oct;35(4):192-6. Review.

PMID:
17921788
16.

Dietary fructose during the suckling period increases body weight and fatty acid uptake into skeletal muscle in adult rats.

Huynh M, Luiken JJ, Coumans W, Bell RC.

Obesity (Silver Spring). 2008 Aug;16(8):1755-62. doi: 10.1038/oby.2008.268. Epub 2008 May 15.

17.

Fuel selection in human skeletal muscle in insulin resistance: a reexamination.

Kelley DE, Mandarino LJ.

Diabetes. 2000 May;49(5):677-83. Review.

PMID:
10905472
18.

Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.

Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR.

Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E354-62. Epub 2003 Apr 15.

PMID:
12700163
19.

FAT/CD36-null mice reveal that mitochondrial FAT/CD36 is required to upregulate mitochondrial fatty acid oxidation in contracting muscle.

Holloway GP, Jain SS, Bezaire V, Han XX, Glatz JF, Luiken JJ, Harper ME, Bonen A.

Am J Physiol Regul Integr Comp Physiol. 2009 Oct;297(4):R960-7. doi: 10.1152/ajpregu.91021.2008. Epub 2009 Jul 22.

PMID:
19625692
20.

A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.

Finck BN, Bernal-Mizrachi C, Han DH, Coleman T, Sambandam N, LaRiviere LL, Holloszy JO, Semenkovich CF, Kelly DP.

Cell Metab. 2005 Feb;1(2):133-44.

Supplemental Content

Support Center